TP53 and neoplasm: Although there was a trend toward decreased survival in the Sirt2−/−; p53+/− mice under HFD, they seemed to be partially protected as the decrease in tumor incidence did not reach statistical significance (Sirt2−/−; p53+/−: HFD vs. ctrl survival p = 0.01 / tumor incidence p = 0.1).